Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionSG Americas Securities, LLC
Latest Disclosed Ownership56,982 shares
Latest Disclosed Value $ 25,445
SG Americas Securities, LLC ownership in VRTX / Vertex Pharmaceuticals Incorporated

On April 16, 2026 - SG Americas Securities, LLC filed a 13F-HR form disclosing ownership of 56,982 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $25,444,742 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 9, 2026 disclosing 115,899 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -50.83% during the quarter. The current value of the position is $25,461,267 USD.

SG Americas Securities, LLC has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 56,982 -58,917 -50.83 25 -51.92 0.0273
2026-01-09 2025-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 115,899 55,837 92.97 53 126.09 0.0671
2025-10-23 2025-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 60,062 -55,578 -48.06 24 -54.90 0.0793
2025-08-08 2025-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 115,640 93,367 419.19 51 410.00 0.2139
2025-04-15 2025-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 22,273 17,502 366.84 11 900.00 0.0354
2025-01-17 2024-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 4,771 -30,560 -86.50 2 -93.75 0.0079
2024-10-03 2024-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 35,331 -43,198 -55.01 16 -55.56 0.0596
2024-07-12 2024-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 78,529 48,495 161.47 37 200.00 0.2145
2024-05-06 2024-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 30,034 1,911 6.80 13 9.09 0.0604
2024-01-12 2023-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 28,123 14,427 105.34 11 175.00 0.1067
2023-10-13 2023-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 13,696 -16,367 -54.44 5 -60.00 0.0545
2023-07-10 2023-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 30,063 13,487 81.36 11 100.00 0.0800
2023-04-28 2023-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 16,576 -1,869 -10.13 5 0.00 0.0607
2023-02-02 2022-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 18,445 4,112 28.69 5 -99.88 0.0649
2022-10-31 2022-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 14,333 -25,284 -63.82 4,150 -62.83 0.0514
2022-07-29 2022-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 39,617 -35,668 -47.38 11,164 -43.18 0.1188
2022-04-29 2022-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 75,285 41,131 120.43 19,647 161.96 0.1441
2022-02-07 2021-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 34,154 25,894 313.49 7,500 400.67 0.0408
2021-11-01 2021-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 8,260 -114,990 -93.30 1,498 -93.97 0.0070
2021-08-12 2021-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 123,250 91,977 294.11 24,851 269.81 0.1156
2021-05-13 2021-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 31,273 -13,996 -30.92 6,720 -37.19 0.0352
2021-02-04 2020-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 45,269 16,177 55.61 10,699 35.14 0.0571
2020-11-09 2020-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 29,092 -15,628 -34.95 7,917 -39.02 0.0504
2020-07-20 2020-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 44,720 22,953 105.45 12,983 150.69 0.1081
2020-04-30 2020-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 21,767 875 4.19 5,179 13.23 0.0486
2020-01-28 2019-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 20,892 -68,170 -76.54 4,574 -69.69 0.0417
2019-11-04 2019-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 89,062 55,071 162.02 15,089 142.08 0.1237
2019-07-29 2019-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 33,991 17,724 108.96 6,233 108.32 0.0429
2019-04-29 2019-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 16,267 14,328 738.94 2,992 832.09 0.0275
2019-01-31 2018-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 1,939 -84,768 -97.76 321 -98.08 0.0028
2018-11-06 2018-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 86,707 48,849 129.03 16,712 159.75 0.1238
2018-08-07 2018-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 37,858 -28,889 -43.28 6,434 -40.85 0.0580
2018-05-03 2018-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 66,747 51,539 338.89 10,878 377.31 0.0870
2018-01-24 2017-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 15,208 -74 -0.48 2,279 -1.89 0.0213
2017-11-07 2017-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 15,282 1,473 10.67 2,323 30.51 0.0204
2017-08-03 2017-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 13,809 -26,507 -65.75 1,780 -59.63 0.0160
2017-05-10 2017-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 40,316 -58,389 -59.16 4,409 -39.37 0.0390
2017-02-08 2016-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 98,705 75,606 327.31 7,272 261.07 0.0610
2017-02-08 2016-09-30 13F/A-1 VERTEX PHARMACEUTICALS INC COM COM 92532F100 23,099 4,031 21.14 2,014 22.80 0.0211
2016-11-08 2016-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 23,099 2,014
2016-08-03 2016-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 19,068 -31,434 -62.24 1,640 -59.14 0.0116
2016-05-12 2016-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 50,502 -61,662 -54.97 4,014 -71.56 0.0290
2016-02-12 2015-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 112,164 100,164 834.70 14,114 6,404.15 0.1002
2015-11-09 2015-09-30 13F VERTEX PHARMACEUTICALS OPT 92532F950 12,000 -211,832 -94.64 217 -99.21 0.0013
2015-11-09 2015-09-30 13F VERTEX PHARMACEUTICALS OPT 92532F900 12,000 0 140 0.0008
2015-11-09 2015-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 51,895 -171,937 5,404 0.0323
2015-08-06 2015-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 223,832 95,318 74.17 27,639 82.30 0.1821
2015-05-13 2015-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 128,514 -65,410 -33.73 15,161 -34.19 0.0902
2015-02-12 2014-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 193,924 -79,497 -29.07 23,038 -24.98 0.1132
2014-11-13 2014-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 273,421 29,615 12.15 30,708 33.03 0.1807
2014-08-13 2014-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 243,806 -117,644 -32.55 23,084 -9.69 0.1338
2014-05-14 2014-03-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 361,450 85,159 30.82 25,562 24.52 0.1107
2014-02-12 2013-12-31 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 276,291 -256,263 -48.12 20,528 -49.16 0.0855
2013-11-12 2013-09-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 532,554 344,265 182.84 40,378 168.49 0.1657
2013-08-13 2013-06-30 13F VERTEX PHARMACEUTICALS INC COM COM 92532F100 188,289 188,289 15,039 0.0735
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-04-16 2026-03-31 13F VERTEX PHARMACEUTICALS OPT Call 0 -100.00 0 n/a n/a n/a
2026-01-09 2025-12-31 13F VERTEX PHARMACEUTICALS OPT Call 55,100 0 n/a n/a n/a
2025-01-17 2024-12-31 13F VERTEX PHARMACEUTICALS OPT Call 0 -100.00 0 n/a n/a n/a
2024-10-03 2024-09-30 13F VERTEX PHARMACEUTICALS OPT Call 2,400 60.00 0 n/a n/a n/a
2024-07-12 2024-06-30 13F VERTEX PHARMACEUTICALS OPT Call 1,500 -82.56 0 n/a n/a n/a
2024-05-06 2024-03-31 13F VERTEX PHARMACEUTICALS OPT Call 8,600 -84.07 0 -100.00 n/a n/a n/a
2024-01-12 2023-12-31 13F VERTEX PHARMACEUTICALS OPT Call 54,000 -9.40 1 n/a n/a n/a
2023-10-13 2023-09-30 13F VERTEX PHARMACEUTICALS OPT Call 59,600 1,092.00 1 n/a n/a n/a
2023-07-10 2023-06-30 13F VERTEX PHARMACEUTICALS OPT Call 5,000 -94.32 0 -100.00 n/a n/a n/a
2023-04-28 2023-03-31 13F VERTEX PHARMACEUTICALS OPT Call 88,000 780.00 1 n/a n/a n/a
2023-02-02 2022-12-31 13F VERTEX PHARMACEUTICALS OPT Call 10,000 25.00 0 -100.00 n/a n/a n/a
2022-10-31 2022-09-30 13F VERTEX PHARMACEUTICALS OPT Call 8,000 -38.46 281 -41.70 n/a n/a n/a
2022-07-29 2022-06-30 13F VERTEX PHARMACEUTICALS OPT Call 13,000 -87.06 482 -84.10 n/a n/a n/a
2022-04-29 2022-03-31 13F VERTEX PHARMACEUTICALS OPT Call 100,500 570.00 3,032 338.15 n/a n/a n/a
2022-02-07 2021-12-31 13F VERTEX PHARMACEUTICALS OPT Call 15,000 692 n/a n/a n/a
2021-02-04 2020-12-31 13F VERTEX PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-09 2020-09-30 13F VERTEX PHARMACEUTICALS OPT Call 40,000 56 n/a n/a n/a
2017-05-10 2017-03-31 13F VERTEX PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-08 2016-12-31 13F VERTEX PHARMACEUTICALS OPT Call 12,000 0.00 0 -100.00 n/a n/a n/a
2017-02-08 2016-09-30 13F/A VERTEX PHARMACEUTICALS OPT Call 12,000 0.00 11 -35.29 n/a n/a n/a
2016-11-08 2016-09-30 13F VERTEX PHARMACEUTICALS OPT Call 12,000 11 n/a n/a n/a
2016-08-03 2016-06-30 13F VERTEX PHARMACEUTICALS OPT Call 12,000 0.00 17 -34.62 n/a n/a n/a
2016-05-12 2016-03-31 13F VERTEX PHARMACEUTICALS OPT Call 12,000 0.00 26 -90.11 n/a n/a n/a
2016-02-12 2015-12-31 13F VERTEX PHARMACEUTICALS OPT Call 12,000 0.00 263 911.54 n/a n/a n/a
2015-11-09 2015-09-30 13F VERTEX PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-06 2015-06-30 13F VERTEX PHARMACEUTICALS OPT Call 12,000 0.00 290 5.07 n/a n/a n/a
2015-05-13 2015-03-31 13F VERTEX PHARMACEUTICALS OPT Call 12,000 276 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-05-06 2024-03-31 13F VERTEX PHARMACEUTICALS OPT Put 0 -100.00 0 n/a n/a n/a
2024-05-06 2024-03-31 13F VERTEX PHARMACEUTICALS OPT Put 0 0 n/a n/a n/a
2024-01-12 2023-12-31 13F VERTEX PHARMACEUTICALS OPT Put 15,000 0.00 0 n/a n/a n/a
2023-10-13 2023-09-30 13F VERTEX PHARMACEUTICALS OPT Put 15,000 36.36 0 n/a n/a n/a
2023-07-10 2023-06-30 13F VERTEX PHARMACEUTICALS OPT Put 11,000 0.00 0 n/a n/a n/a
2023-04-28 2023-03-31 13F VERTEX PHARMACEUTICALS OPT Put 11,000 0 n/a n/a n/a
2023-02-02 2022-12-31 13F VERTEX PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-10-31 2022-09-30 13F VERTEX PHARMACEUTICALS OPT Put 13,400 -33.00 21 -87.65 n/a n/a n/a
2022-07-29 2022-06-30 13F VERTEX PHARMACEUTICALS OPT Put 20,000 0.00 170 -52.51 n/a n/a n/a
2022-04-29 2022-03-31 13F VERTEX PHARMACEUTICALS OPT Put 20,000 -80.00 358 -29.80 n/a n/a n/a
2022-02-07 2021-12-31 13F VERTEX PHARMACEUTICALS OPT Put 100,000 0.00 510 -86.45 n/a n/a n/a
2021-11-01 2021-09-30 13F VERTEX PHARMACEUTICALS OPT Put 100,000 0.00 3,764 30.24 n/a n/a n/a
2021-08-12 2021-06-30 13F VERTEX PHARMACEUTICALS OPT Put 100,000 2,890 n/a n/a n/a
2020-07-20 2020-06-30 13F VERTEX PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-04-30 2020-03-31 13F VERTEX PHARMACEUTICALS OPT Put 15,200 1 n/a n/a n/a
2017-05-10 2017-03-31 13F VERTEX PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-08 2016-12-31 13F VERTEX PHARMACEUTICALS OPT Put 12,000 0.00 301 65.38 n/a n/a n/a
2017-02-08 2016-09-30 13F/A VERTEX PHARMACEUTICALS OPT Put 12,000 0.00 182 -30.80 n/a n/a n/a
2016-11-08 2016-09-30 13F VERTEX PHARMACEUTICALS OPT Put 12,000 182 n/a n/a n/a
2016-08-03 2016-06-30 13F VERTEX PHARMACEUTICALS OPT Put 12,000 0.00 263 -11.74 n/a n/a n/a
2016-05-12 2016-03-31 13F VERTEX PHARMACEUTICALS OPT Put 12,000 0.00 298 127.48 n/a n/a n/a
2016-02-12 2015-12-31 13F VERTEX PHARMACEUTICALS OPT Put 12,000 0.00 131 -56.04 n/a n/a n/a
2015-11-09 2015-09-30 13F VERTEX PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-06 2015-06-30 13F VERTEX PHARMACEUTICALS OPT Put 12,000 0.00 142 -26.04 n/a n/a n/a
2015-05-13 2015-03-31 13F VERTEX PHARMACEUTICALS OPT Put 12,000 192 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.